Leon Caly
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Parasitic Diseases Research and Treatment
- SARS-CoV-2 detection and testing
- Virology top 2%
- Poxvirus research and outbreaks
Papers in ⓘ
-
- SARS-CoV-2 and COVID-19 Research 7
- Viral Infections and Vectors 7
- Viral gastroenteritis research and epidemiology 5
- Epidemiology 12
- Respiratory viral infections research 8
- Co-authors
- David A. Jans (11 shared papers)Julian Druce (16 shared papers)Kylie M. Wagstaff (2 shared papers)Mike Catton (2 shared papers)Ronald W.A.L. Limpens (1 shared paper)Montserrat Bárcena (1 shared paper)Igor A. Sidorov (1 shared paper)Jutte J.C. de Vries (1 shared paper)
- Journals
- Viruses (3 papers)Journal of Medical Virology (2 papers)Antiviral Research (2 papers)Emerging infectious diseases (2 papers)The Medical Journal of Australia (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Leon Caly
30 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Infectious Diseases 1.8k
- Virology 258
- Applied Microbiology and Biotechnology 68
- Parasitology 148
- Neurology 320
Countries citing papers authored by Leon Caly
This map shows the geographic impact of Leon Caly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leon Caly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leon Caly more than expected).
Fields of papers citing papers by Leon Caly
This network shows the impact of papers produced by Leon Caly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leon Caly. The network helps show where Leon Caly may publish in the future.
Co-authors
The 25 scholars most cited alongside Leon Caly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro Hit paper breakdown → | 2020 | 1478 |
| 2 | 2020 | 351 | |
| 3 | 2020 | 158 | |
| 4 | 2022 | 115 | |
| 5 | 2012 | 87 | |
| 6 | 2022 | 59 | |
| 7 | 2015 | 47 | |
| 8 | 2003 | 38 | |
| 9 | 2014 | 32 | |
| 10 | 2008 | 30 | |
| 11 | 2021 | 24 | |
| 12 | 2018 | 23 | |
| 13 | 2022 | 22 | |
| 14 | 2017 | 22 | |
| 15 | 2019 | 14 | |
| 16 | 2019 | 11 | |
| 17 | 2019 | 11 | |
| 18 | 2015 | 10 | |
| 19 | 2017 | 10 | |
| 20 | 2018 | 9 |
About Leon Caly
Leon Caly is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Virology and Public Health, Environmental and Occupational Health, having authored 31 papers that have together received 2.6k indexed citations. Recurring topics across this work include Respiratory viral infections research (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Viral Infections and Vectors (7 papers), Mosquito-borne diseases and control (6 papers), Animal Virus Infections Studies (5 papers), Viral gastroenteritis research and epidemiology (5 papers), Poxvirus research and outbreaks (4 papers) and HIV Research and Treatment (3 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Virology (258 citations), Applied Microbiology and Biotechnology (68 citations), Parasitology (148 citations) and Neurology (320 citations). Leon Caly has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include David A. Jans, Julian Druce, Kylie M. Wagstaff, Mike Catton, Ronald W.A.L. Limpens, Montserrat Bárcena, Igor A. Sidorov, Jutte J.C. de Vries, Natacha S. Ogando and Marjolein Kikkert. Their work appears in journals such as Viruses, Journal of Medical Virology, Antiviral Research, Emerging infectious diseases and The Medical Journal of Australia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.